Evidence map›Paper›PMID 35863022›Full record

ArticleMicrobiology spectrum2022

Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis.

Kenneth C Malcolm, Emily A Wheeler, Kara Calhoun, Patricia M Lenhart-Pendergrass, Noel Rysavy, Katie R Poch, Silvia M Caceres, Milene T Saavedra, Jerry A Nick

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Divergent host humoral innate immune response to the smooth-to-rough adaptation ofFrontiers in cellular and infection microbiology · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kenneth C MalcolmDepartment of Medicine, National Jewish Healthgrid.240341.0, Denver, Colorado, USA.ORCID 0000-0002-8097-6059
Emily A WheelerDepartment of Medicine, National Jewish Healthgrid.240341.0, Denver, Colorado, USA.
Kara CalhounDepartment of Medicine, University of Colorado, Aurora, Colorado, USA.ORCID 0000-0001-9815-5331
Patricia M Lenhart-PendergrassDepartment of Pediatrics, University of Colorado, Aurora, Colorado, USA.
Noel RysavyDepartment of Medicine, National Jewish Healthgrid.240341.0, Denver, Colorado, USA.
Katie R PochDepartment of Medicine, National Jewish Healthgrid.240341.0, Denver, Colorado, USA.
Silvia M CaceresDepartment of Medicine, National Jewish Healthgrid.240341.0, Denver, Colorado, USA.
Milene T SaavedraDepartment of Medicine, National Jewish Healthgrid.240341.0, Denver, Colorado, USA.
Jerry A NickDepartment of Medicine, National Jewish Healthgrid.240341.0, Denver, Colorado, USA.ORCID 0000-0002-8910-3449
National Jewish Health · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Viral-induced Adaptation of Neutrophil Response in ARDSR01HL090991 · NHLBI · NATIONAL JEWISH HEALTH · PI NICK, JERRY A · 2007 to 2010
$1.7M
Prospective Longitudinal Assessment of Culture-Independent Molecular Airway Markers of Nontuberculous MycobacteriaR01HL146228 · NHLBI · NATIONAL JEWISH HEALTH · PI HILL, JANE, NICK, JERRY A · 2019 to 2022
$1.7M
NHLBI NIH HHS R01 HL090991NHLBI NIH HHS R01 HL146228
6 · The paper itself

Abstract

Nontuberculous mycobacteria (NTM) infections are increasingly prevalent in chronic lung diseases, including cystic fibrosis (CF). Mycobacterium abscessus is of particular concern due to relatively greater virulence and intrinsic antimicrobial resistance. Airway culture identification, the standard method for detecting pulmonary infection, is hindered by low sensitivity, long culture times, and reliance on sputum production or lavage. A culture-independent test for detecting NTM infection could complement, or replace, sputum culture, which is becoming more difficult to obtain with reduced sputum production by people with CF (pwCF) on highly effective modulator therapy. We describe an assay for the detection of plasma anti-M. abscessus antibodies of pwCF to antigens from M. abscessus lysates. Anti-M. abscessus IgG and IgA, but not IgM, discriminated with high specificity subjects infected with M. abscessus from those infected by M. avium complex, and from those with distant or no NTM infections. The IgG3 subclass predominated with minor contributions by other subclasses. Both aqueous and organic soluble antigens were recognized by plasma IgG. A validation cohort measuring IgG and IgG3 identified M. abscessus positive subjects, and elevated IgG was sustained over several years. These studies show the benefit of M. abscessus cell lysates to detect plasma IgG of subjects with CF and M. abscessus infections. Subclass analysis suggests that IgG3 is the predominant subtype in these subjects with chronic bacterial infections suggesting a defect in class maturation. Serodiagnosis could be useful to monitor M. abscessus group infections in chronic lung disease as an adjunct or alternative to culture.

Indexed as

Cystic FibrosisMycobacterium abscessusMycobacterium Infections, NontuberculousHumansImmunoglobulin GNontuberculous MycobacteriaImmunoglobulin Gcystic fibrosisELISAimmunoglobulinsnontuberculous mycobacteriaserodiagnosis

Identifiers

PMID35863022
PMCPMC9430546
OpenAlexW4283832798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.